1. The fungal secondary metabolite trichodimerol inhibits TGF-β dependent cellular effects and tube formation of MDA-MB-231 cells

   • Annegret Serwe
   • Timm Anke
   • Gerhard Erkel

   PRECLINICAL STUDIES 14 November 2008 Pages: 491 - 502

   

2. Regression of Dalton’s lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand

   • Raj K. Koiri
   • Surendra K. Trigun
   • Santosh K. Dubey

   PRECLINICAL STUDIES 29 November 2008 Pages: 503 - 516

   

3. Boldine: a potential new antiproliferative drug against glioma cell lines

   • Daniéli Gerhardt
   • Ana Paula Horn
   • Christianne Salbego

   PRECLINICAL STUDIES 03 December 2008 Pages: 517 - 525

   

4. Inhibitory effect of tea polyphenols on hepatic preneoplastic foci in Wistar rats

   • Smita Srivastava
   • Madhulika Singh
   • Yogeshwer Shukla

   PRECLINICAL STUDIES 05 December 2008 Pages: 526 - 533

   

5. Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: A structure–activity relationship study

   • S. B. Benaka Prasad
   • K. Vinaya
   • K. S. Rangappa

   PRECLINICAL STUDIES 06 December 2008 Pages: 534 - 542

   

6. Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis

   • Ansgar Brüning
   • Petra Burger
   • Alexander Burges

   PRECLINICAL STUDIES 28 November 2008 Pages: 543 - 551

   

7. “Classical 3 + 3 design” versus “accelerated titration designs”: analysis of 270 phase 1 trials investigating anti-cancer agents

   • Nicolas Penel
   • Nicolas Isambert
   • Jacques Bonneterre

   PHASE I STUDIES 10 January 2009 Pages: 552 - 556

8. Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol

   • Clovis O. Da Fonseca
   • Julio Thome Silva
   • Thereza Quirico-Santos

   PHASE I STUDIES 13 January 2009 Pages: 557 - 564

   

9. A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

   • Lida Mina
   • Ian Krop
   • Kathy D. Miller

   PHASE II STUDIES 13 February 2009 Pages: 565 - 570

10. Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer

    • Bryan J. Schneider
    • Francis P. Worden
    • Gregory P. Kalemkerian

    PHASE II STUDIES 19 February 2009 Pages: 571 - 578

    

11. Trastuzumab-induced CCL20 and interleukin-8 mRNA in human whole blood ex vivo

    • Setsuo Hasegawa
    • Hideaki Kato
    • Masato Mitsuhashi

    SHORT REPORT 10 February 2009 Pages: 579 - 582

    

12. Wound healing delay after central venous access following DCF/VEGF-trap therapy

    • Charles Ferté
    • Christophe Massard
    • Jean-Charles Soria

    SHORT REPORT 17 February 2009 Pages: 583 - 585

    

13. Cyclin-dependent kinase inhibitors as potential targeted anticancer agents

    • Ivan Diaz-Padilla
    • Lillian L. Siu
    • Ignacio Duran

    Review 05 March 2009 Pages: 586 - 594